[
  {
    "ts": null,
    "headline": "Evaluating DaVita Stock After a 27.3% Drop This Year",
    "summary": "Wondering if DaVita stock is trading at a bargain or an inflated premium? You are not alone, especially with so much chatter about where opportunities really lie in this market. Despite impressive gains of 62.7% across three years, DaVita’s stock has stumbled more recently, with a one-year drop of 27.3% and a decline of 19.7% year-to-date. Recent headlines have shone a spotlight on DaVita’s evolving operating environment, especially as healthcare policy debates and shifting competitive...",
    "url": "https://finnhub.io/api/news?id=7e334a200a6ca0f5080b8dcbfaf277515583fbf21f4753ff702e968a28688d38",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763831948,
      "headline": "Evaluating DaVita Stock After a 27.3% Drop This Year",
      "id": 137579325,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "Wondering if DaVita stock is trading at a bargain or an inflated premium? You are not alone, especially with so much chatter about where opportunities really lie in this market. Despite impressive gains of 62.7% across three years, DaVita’s stock has stumbled more recently, with a one-year drop of 27.3% and a decline of 19.7% year-to-date. Recent headlines have shone a spotlight on DaVita’s evolving operating environment, especially as healthcare policy debates and shifting competitive...",
      "url": "https://finnhub.io/api/news?id=7e334a200a6ca0f5080b8dcbfaf277515583fbf21f4753ff702e968a28688d38"
    }
  }
]